Anyone that thinks kensington was not going into operation is dreaming really.Last Night CDE never looked back once one buyer purchased 100,000 at $4.02
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come